| St. Jude Medical announces first clinical use of renal denervation technology. |
|
| Marketwatch: The technology was developed as a treatment for resistant hypertension (high blood pressure that is not well controlled by drug therapy). Prof. Stephen Worthley, Helpman Chair of Cardiovascular Medicine at the University of Adelaide, performed the first procedure at the Royal Adelaide Hospital in South Australia. |